Cost-Saving MeasuresOPKO has identified additional cost-saving measures, targeting $10 million in annualized cost reductions.
Diagnostics Segment ImprovementOPKO Health's diagnostics segment showed a significant improvement, with a reduction in operating losses compared to the previous year.
Partnership And ExpansionOPKO entered an agreement with Labcorp for Labcorp to acquire laboratory testing businesses focused on oncology and oncology-related clinical testing services across the U.S. from BioReference Health, a wholly owned subsidiary of OPKO.